ABSTRACT: Neurologic manifestations, afflicting up to 70% of SLE patients, include psychosis, seizures, chorea, neuropathies, and stroke. MRI is useful in evaluation of lupus patients and several reports have documented cerebral atrophy or focal hyperintensities. We report an unusual MRI appearance in a 56-year-old woman with SLE, diagnosed on the basis of pleuritis, lymphopenia, anti-DNA antibodies, and neurologic involvement. She reported recent onset of Raynaud's phenomenon and generalized macular rash. She presented after two months of gradual deterioration with memory loss, flattened affect, dysphagia, dysarthria, anomia, and somnolence, without focal neurologic signs. Investigations included elevated ESR, reduced complement, normal CSF without oligoclonal bands, negative viral serology, normal hormone and vitamin levels, normal renal and hepatic function. Neuropsychologic testing showed widespread impairment (WAIS-R: FSIQ-63; WMS-69; DRS-98; RCPM-14; WAB AQ-78.8). CT was normal but MRI showed strikingly symmetric, confluent hyperintensities extensively involving cerebral and cerebellar white matter on Tl and T2 weighted scans. Basal ganglia and subependymal and subcortical white matter were spared. Treated with prednisone, the patient made a gradual, but incomplete, recovery. These MRI findings may reflect widespread vasculopathy or direct immunologic brain insult with or without imunologic blood-brain barrier disruption. RESUME: Demence avec leuco-encephalopathie dans le lupus erythemateux aigu dissemine. Les manifestations neurologiques qui touchent plus de 70% des patients atteints de lupus erythemateux aigu dissemine (LEAD) incluent la psychose, les convulsions, la choree, les neuropathies et l'ictus cerebral. L'imagerie par resonnance magnetique (IRM) est utile dans 1'evaluation des patients souffrant de lupus et plusieurs communications ont documente une atrophie cerebrale ou des foyers hyperintenses. Nous rapportons le cas d'une femme agee de 56 ans atteinte de LEAD, dont le diagnostic avait ete pose sur la base d'une pleurite, d'une lymphopenie, de la presence d'anticorps anti-ADN et d'une atteinte neurologique, et chez qui l'imagerie par resonnance magnetique presentait un aspect inusite. Elle rapportait le debut recent d'un phenomene de Raynaud et une irruption maculaire generalised. Elle a consulte suite a une periode de deterioration de deux mois, avec une alteration de la memoire, une athymie, une dysphagie, une dysarthrie, une anosmie et de la somnolence, sans signe neurologique focal. L'investigation a montre une elevation de la vitesse de sedimentation, un taux s6rique du complement abaisse, un LCR normal sans bande oligoclonale, une serologic virale negative, des niveaux d'hormones et de vitamines normaux, une fonction renale et hepatique normale. Les epreuves neuropsychologiques ont montre une atteinte etendue (WAIS-R : FSIQ-63; WMS-69; DRS-98; RCPM-14, WAB AQ-78.8). La tomodensitometrie etait normale, mais 1'IRM a montre des zones confluentes d'hyperintensite, remarquablement symetriques, impliquent la substance blanche cerebrale et cerebelleuse a l'imagerie ponderee par Tl et T2. Les ganglions de la base et la substance blanche sous-ependymaire et sous-corticale etaient epargnes. La patiente a recupere graduellement mais incompletement sous prednisone. Ces constatations a 1TRM peuvent refleter une vasculopathie etendue ou une atteinte immunologique directe du cerveau avec ou sans perturbation de la barriere hemoencephalique.
1 neurologic complications are clinically manifest in 50-70% of SLE patients. 2 " 4 Occasionally the initial disease manifestation, neurologic SLE may first present in the final weeks of life in up to a third of patients. 2 Like systemic features, neurologic manifestations of SLE are protean and the nervous system can be affected at any level. 2 Study of neurologic SLE has been hampered by the lack of a generally accepted clinical or pathophysiologic classification.
Tentative classification systems 5 generally attempt to distinguish first between primary CNS lupus and the more common 6 secondary CNS manifestations ascribed to systemic disease, infection, or therapy.
Cognitive impairment is the most common neurologic finding in SLE, occurring in up to 66% of patients, including almost half of patients without overt neurologic symptomatology. involvement in SLE. In another neuropsychologic study, Sonies et al. 9 concluded that SLE patients, especially those with psychiatric involvement, suffered from reduced ability to focus and maintain attention in order to complete tasks.
Aside from infections and systemic disorders such as uremia and hypertension, several mechanisms have been suggested to explain cognitive impairment in SLE. Neuropsychologic deficits may result from cerebral infarcts secondary to cardiogenic emboli. 4 Infarcts may be related to the presence of antiphospholipid antibodies 10 and multi-infarct dementia has been described in association with these antibodies. 11 -12 Much less commonly, deficits may be attributable to immune complex-mediated vasculitis. 213 A noninflammatory small vessel vasculopathy may also occur. 213 Autoantibodies reactive with neuronal cell membranes or cytoskeleton have been identified in the serum and CSF of up to 75% of SLE patients and may be of higher titer in those with neurologic manifestations.
14 " 19 Thus, direct immunologic injury to neurons has been proposed as a potential mechanism for neurologic SLE. Some have suggested that, in addition to antineuronal antibodies, an alteration in the blood-brain barrier is also required. 3 ' 20 Fields and colleagues 21 found anticardiolipin antibodies in the serum but not the CSF of SLE patients with "infarct-like" lesions on MRI. Although anticardiolipin antibody has been linked with cerebral infarction and migraine, 1022 it seems less likely that it plays a direct role in diffuse cerebral dysfunction. 21 Cognitive impairment is SLE thus appears to reflect heterogeneous patterns of deficits which may result from several distinct pathological processes. There is some evidence 23 that patients with brain cross-reactive lymphocytotoxic antibodies tend to share a particular pattern of impairment (mainly visuospatial) despite the overall neuropsychologic variability found in SLE patients.
CT scanning has identified atrophy, hematomas, and infarcts in SLE. [24] [25] [26] [27] [28] MRI has proven more sensitive. 29 " 32 Several investigations have documented atrophy, infarcts, and hematomas on MRI.
19 ' 29-34 These same studies have also revealed lesions not typically seen on CT. These include focal hyperintensities in white matter, in gray matter, and at the corticomedullary junction and vary from large single lesions to multiple tiny abnormalities. McCune et al. 31 found that focal lesions were much more common in patients with focal signs than in those with nonspecific cognitive decline. Sewell et al. 35 maintained that the yield from MRI is small unless a focal lesion is suggested clinically. The relationship between these focal abnormalities often seen on MRI and cognitive impairment, the commonest neurologic manifestation of SLE, is still unclear.
CASE REPORT
Two months prior to presentation at St. Joseph's Health Centre in August, 1987, S.N., a previously healthy 56-year-old high-school-educated homemaker, developed a generalized erythematous macular rash which resolved completely after several days. At about the same time, she developed typical Raynaud's phenomenon (which persisted) and intermittent diarrhea. Over the next two months, there was steady neurological decline. She became forgetful, leaving faucets running and burners on. She became somnolent and uninterested in her surroundings. Affect was blunted. She no longer initiated conversation and was slow to respond to questions. According to her family, S.N. was normally outgoing and gregarious, with many social contacts and a ready wit. Her voice became quiet, slurred, and halting. Dysphagia developed with occasional choking, particularly on liquids. She had frequent hiccups.
There was no history of fever, chills, or sweats. She had no previous history of skin rashes or neurologic complaints. She had never suffered from photosensitivity, dry eyes or mouth, alopecia, arthralgias, or mucosal ulcers. S.N. had been taking no medications and had no allergies. Apart from an episode of jaundice in her 20's she had been free of illness. There was no family history of rheumatologic or neurologic disease.
On examination, S.N., although awake, was confused and extremely withdrawn, with flat affect. Vital signs and general examination were normal. She was disoriented to time and place. Speech was hypophonic, dysarthric, and hesitant. There were occasional phonemic paraphasias. Naming and repetition were impaired. After a long delay, she followed most simple commands. Instances of verbal and motor perseveration were observed. She could repeat only three digits forward and was unable to do serial 7's or 3's. She remembered none of three objects after one minute. Writing was poorly formed and illegible. She read only simple sentences. Her drawings were simplified scrawls. There was no evidence of hemispatial neglect. She could tell left from right. Thinking was concrete. Praxis was normal. Cranial nerves and fundi were normal. Motor examination was normal apart from mild gegenhalten, more marked on the right. Sensory examination was normal, as were deep tendon reflexes. Plantar responses were flexor. Palmomental reflexes were present bilaterally. Glabellar tap produced sustained blinking. There was no grasp response. Gait was slow and shuffling but she could perform tandem gain adequately. Her vocal cords were seen to move normally on indirect laryngoscopy.
Within a week of admission, S.N. developed chest pain and was found to have bilateral pleural effusions not seen on a radiograph done nine days previously. Thoracentesis revealed these to be exudative. No organisms were grown from the fluid.
Investigations carried out on S.N. are summarized in Table I . Neuropsychologic testing revealed marked global cognitive dysfunction (Table 2 ). Serum and CSF viral serology and cultures were negative, as was HIV titer. Vitamin B12, folate, plasma ACTH, liver enzymes, urea, creatinine, urinalysis, blood sugar, thyroid function, PT, PTT, and 2-D echocardiogram were all normal. Electroencephalogram showed 9 Hz alpha rhythm with normal reactivity and intermittent bursts of theta and delta in both frontotemporal regions. An isotope brain scan was normal. CT scan was also completely normal. HMPAO-SPECT scanning showed diminished flow bilaterally in the frontal lobes. Acute MRI scans (Figure 1 ), demonstrated extensive, confluent hyperintensity of the cerebral and cerebellar white matter which was bilateral and symmetric. Shortly after admission, S.N. was started on prednisone 80 mg daily. Over the next three weeks in hospital, there was a marked improvement in her spontaneity, affect, grooming, and cognition. Prednisone was gradually tapered to zero over the next ten months. Within two months she was again able to cook, shop, and do her usual housework. Her speech and swallowing had improved greatly. Within a year of her initial presentation, she had reached a plateau. Since that time, she has been left with mild hypophonia and some trouble with her memory. Her family feels that her affect and spontaneity are back to normal. She is able to carry out her household duties as before. Her neuropsychologic improvement is documented in Table 2 . Follow-up MRI scans up to 29 months after presentation showed progressive cerebral atrophy and shrinkage of the abnormal areas of white matter (Figure 2 ).
DISCUSSION
-This woman's illness, characterized by four of the American Rheumatism Association's major diagnostic criteria 36 (pleuritis, lymphopenia, neurologic disorder, and anti-DNA antibodies) and by skin rash, Raynaud's phenomenon, hypocomplementemia, anticardiolipin antibodies, evidence of circulating immune complexes, and mild thrombocytopenia, is consistent with SLE. Her neurologic condition with generalized cognitive decline and social withdrawal approaching catatonia resembles previous reports of neurologic SLE which, unfortunately, often do not present results of neuropsychologic tests or clearly distinguish between psychosis and dementia which are frequently grouped together as neuropsychiatric lupus or "organic brain syndrome". 5 ' 37 "
39
The pathogenesis of this patient's cognitive impairment is not certain. Given the unique finding of extensive and confluent white matter changes on MRI, the absence of focal signs, and the steady progression of her illness, it seems unlikely that her signs could be explained by multiple infarcts due to cardiac emboli, large vessel arteritis, or a thrombotic diathesis. Degenerative and proliferative changes affecting small vessels extremely diffusely throughout the brain 2 might be implicated, as might direct immunologic damage to brain with or without disturbance of the blood-brain barrier.
The striking abnormalities on MRI contrast dramatically with the normal findings on CT, bearing out the greater sensitivity of MRI in neurologic SLE. 2 9 3 2 Contrary to reports that MRI is abnormal mainly in those with focal signs 31 -35 , this case shows that MRI can also be useful in investigating patients with nonfocal neurologic disease in SLE.
Although S.N. was left with some cognitive impairment, her substantial recovery and lack of new symptoms over three years of follow-up illustrate the point that devastating neurologic symptoms early in the disease are not necessarily harbingers of an aggressive or lethal course. 
